1, to strong trees bagging? The object of the bagging is a strong tree, if the plastic film bag sets in the results of weak trees, there will be a phenomenon of fruit, bagging effect is worse than not bagging. 2, before the bagging should be poured once permeated? According to observation, before the bagging water orchard, sunburn fruit is very small, no watering orchard on the day of the more serious fruit. Two to five days after bagging is the peak of sunburn. 3, must be sprayed before bagging a high-quality insecticidal calcium bactericidal agent? If the drug is not sprayed, the fruit will occur ringworm disease, black spot disease, bitter pit disease, bean spot, red spot disease. In addition, plastic bags are generally better than late sets. 4. The bags should be tied tightly, and the bags must be sealed tightly to prevent rain, medicine, and insects from entering the pockets. The main pests that enter the bags are yellow mealworms, pear orchard locusts, aphids, and leaf roller insects. 5, vent must be blown open? If the vent is not open, the temperature inside the bag is too high, it will soften the fruit and no longer grow. Therefore, a high quality plastic film pouch should be used. This kind of pouch will not stick to the fruit and avoid the fruit. Do not take the bag after fruit picking? The fruit in the plastic bag must be bagged, otherwise it will cause the fruit to shrink. Ziprasidone Intermediates
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.
Ziprasidone Intermediates Ziprasidone Intermediates,Cas 7716-66-7 ,Cas 2634-33-5,Ziprasidone Hydrochloride Intermediate Nanjing Sunshine Biotech Co., Ltd , http://www.sunshine-bio.com
Ziprasidone is a medication of the atypical antipsychotic type. It is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in people with schizophrenia. Ziprasidone is also used off-label for depression, bipolar maintenance, and posttraumatic stress disorder.
Ziprazidone is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate.
We produce a series of complete intermediates for Ziprasidone, intermediate I (CAS No. 2634-33-5) and intermediate II (CAS No. 7716-66-7) etc.
